167 related articles for article (PubMed ID: 37141792)
1. Exploring allosteric hits of the NS2B-NS3 protease of DENV2 by structure-guided screening.
Gangopadhyay A; Saha A
Comput Biol Chem; 2023 Jun; 104():107876. PubMed ID: 37141792
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the inhibitory potency of anti-dengue phytocompounds against DENV-2 NS2B-NS3 protease: virtual screening, ADMET profiling and molecular dynamics simulation investigations.
Purohit P; Barik D; Agasti S; Panda M; Meher BR
J Biomol Struct Dyn; 2024 Apr; 42(6):2990-3009. PubMed ID: 37194462
[TBL] [Abstract][Full Text] [Related]
3. Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studies.
Purohit P; Sahoo S; Panda M; Sahoo PS; Meher BR
J Mol Model; 2022 Oct; 28(11):365. PubMed ID: 36274116
[TBL] [Abstract][Full Text] [Related]
4. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
[TBL] [Abstract][Full Text] [Related]
5. Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease.
Sarwar MW; Riaz A; Dilshad SMR; Al-Qahtani A; Nawaz-Ul-Rehman MS; Mubin M
BMC Struct Biol; 2018 Apr; 18(1):6. PubMed ID: 29673347
[TBL] [Abstract][Full Text] [Related]
6. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
Dwivedi VD; Tripathi IP; Mishra SK
J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
[TBL] [Abstract][Full Text] [Related]
7. Investigating Lycotoxin-An1a (An1a), a defense antiviral peptide from Alopecosa nagpag venom as prospective anti-dengue agent against DENV-2 NS2B-NS3 protease.
Purohit P; Barik D; Dansana J; Meher BR
Comput Biol Chem; 2024 Feb; 108():108005. PubMed ID: 38157660
[TBL] [Abstract][Full Text] [Related]
8. A Computational Approach Applied to the Study of Potential Allosteric Inhibitors Protease NS2B/NS3 from Dengue Virus.
Costa RAD; Rocha JAPD; Pinheiro AS; Costa ADSSD; Rocha ECMD; Silva RC; Gonçalves ADS; Santos CBR; Brasil DDSB
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807364
[TBL] [Abstract][Full Text] [Related]
9. 3D-QSAR pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation toward identifying lead compounds for NS2B-NS3 protease inhibitors.
Luo PH; Zhang XR; Huang L; Yuan L; Zhou XZ; Gao X; Li LS
J Recept Signal Transduct Res; 2017 Oct; 37(5):481-492. PubMed ID: 28758854
[TBL] [Abstract][Full Text] [Related]
10. Allosteric pocket of the dengue virus (serotype 2) NS2B/NS3 protease: In silico ligand screening and molecular dynamics studies of inhibition.
Mukhametov A; Newhouse EI; Aziz NA; Saito JA; Alam M
J Mol Graph Model; 2014 Jul; 52():103-13. PubMed ID: 25023665
[TBL] [Abstract][Full Text] [Related]
11. A Critical Observation on the Design and Development of Reported Peptide Inhibitors of DENV NS2B-NS3 Protease in the Last Two Decades.
Murtuja S; Shilkar D; Sarkar B; Sinha BN; Jayaprakash V
Mini Rev Med Chem; 2022; 22(8):1108-1130. PubMed ID: 34720077
[TBL] [Abstract][Full Text] [Related]
12. Repurposing of investigational cancer drugs: Early phase discovery of dengue virus NS2B/NS3 protease inhibitors.
Saleem HN; Kousar S; Jiskani AH; Sohail I; Faisal A; Saeed M
Arch Pharm (Weinheim); 2023 Nov; 356(11):e2300292. PubMed ID: 37582646
[TBL] [Abstract][Full Text] [Related]
13. Allosteric inhibition of the NS2B-NS3 protease from dengue virus.
Yildiz M; Ghosh S; Bell JA; Sherman W; Hardy JA
ACS Chem Biol; 2013 Dec; 8(12):2744-52. PubMed ID: 24164286
[TBL] [Abstract][Full Text] [Related]
14. Structure-guided screening of chemical database to identify NS3-NS2B inhibitors for effective therapeutic application in dengue infection.
Bhowmick S; Alissa SA; Wabaidur SM; Chikhale RV; Islam MA
J Mol Recognit; 2020 Jul; 33(7):e2838. PubMed ID: 32060998
[TBL] [Abstract][Full Text] [Related]
15. Proline-Based Allosteric Inhibitors of Zika and Dengue Virus NS2B/NS3 Proteases.
Millies B; von Hammerstein F; Gellert A; Hammerschmidt S; Barthels F; Göppel U; Immerheiser M; Elgner F; Jung N; Basic M; Kersten C; Kiefer W; Bodem J; Hildt E; Windbergs M; Hellmich UA; Schirmeister T
J Med Chem; 2019 Dec; 62(24):11359-11382. PubMed ID: 31769670
[TBL] [Abstract][Full Text] [Related]
16. Drug repurposing against the RNA-dependent RNA polymerase domain of dengue serotype 3 by virtual screening and molecular dynamics simulations.
Gangopadhyay A; Saha A
J Biomol Struct Dyn; 2023 Jul; 41(11):5152-5165. PubMed ID: 35642087
[TBL] [Abstract][Full Text] [Related]
17. Structural Modifications Introduced by NS2B Cofactor Binding to the NS3 Protease of the Kyasanur Forest Disease Virus.
Kandagalla S; Kumbar B; Novak J
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446083
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in natural products as potential inhibitors of dengue virus with a special emphasis on NS2b/NS3 protease.
Saqallah FG; Abbas MA; Wahab HA
Phytochemistry; 2022 Oct; 202():113362. PubMed ID: 35948138
[TBL] [Abstract][Full Text] [Related]
19. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
Lin KH; Ali A; Rusere L; Soumana DI; Kurt Yilmaz N; Schiffer CA
J Virol; 2017 May; 91(10):. PubMed ID: 28298600
[TBL] [Abstract][Full Text] [Related]
20. Allosteric quinoxaline-based inhibitors of the flavivirus NS2B/NS3 protease.
Zephyr J; Rao DN; Johnson C; Shaqra AM; Nalivaika EA; Jordan A; Kurt Yilmaz N; Ali A; Schiffer CA
Bioorg Chem; 2023 Feb; 131():106269. PubMed ID: 36446201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]